There are many studies demonstrating that EPO/EPOR signalization in cancer cells can: induce cell proliferation [11–14], change the sensitivity to chemotherapeutics [11, 12], induce angiogenesis [15] and/or tumor neovascularization [16]. This evidence concerns the gene EPO and neoplasm.